1. Home
  2. USAR vs GERN Comparison

USAR vs GERN Comparison

Compare USAR & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USAR
  • GERN
  • Stock Information
  • Founded
  • USAR 2019
  • GERN 1990
  • Country
  • USAR United States
  • GERN United States
  • Employees
  • USAR N/A
  • GERN N/A
  • Industry
  • USAR
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • USAR
  • GERN Health Care
  • Exchange
  • USAR NYSE
  • GERN Nasdaq
  • Market Cap
  • USAR 1.1B
  • GERN 853.5M
  • IPO Year
  • USAR N/A
  • GERN 1996
  • Fundamental
  • Price
  • USAR $12.14
  • GERN $1.51
  • Analyst Decision
  • USAR Strong Buy
  • GERN Buy
  • Analyst Count
  • USAR 2
  • GERN 7
  • Target Price
  • USAR $16.00
  • GERN $4.17
  • AVG Volume (30 Days)
  • USAR 2.6M
  • GERN 10.9M
  • Earning Date
  • USAR 08-15-2025
  • GERN 08-07-2025
  • Dividend Yield
  • USAR N/A
  • GERN N/A
  • EPS Growth
  • USAR N/A
  • GERN N/A
  • EPS
  • USAR 0.13
  • GERN N/A
  • Revenue
  • USAR N/A
  • GERN $116,293,000.00
  • Revenue This Year
  • USAR N/A
  • GERN $160.12
  • Revenue Next Year
  • USAR N/A
  • GERN $55.01
  • P/E Ratio
  • USAR $91.72
  • GERN N/A
  • Revenue Growth
  • USAR N/A
  • GERN 22264.04
  • 52 Week Low
  • USAR $5.56
  • GERN $1.17
  • 52 Week High
  • USAR $20.00
  • GERN $5.06
  • Technical
  • Relative Strength Index (RSI)
  • USAR N/A
  • GERN 51.36
  • Support Level
  • USAR N/A
  • GERN $1.42
  • Resistance Level
  • USAR N/A
  • GERN $1.58
  • Average True Range (ATR)
  • USAR 0.00
  • GERN 0.10
  • MACD
  • USAR 0.00
  • GERN -0.01
  • Stochastic Oscillator
  • USAR 0.00
  • GERN 40.00

About USAR USA RARE EARTH INC

USA Rare Earth Inc is a vertically integrated, domestic rare earth magnet supply chain that supports the state of energy, mobility, and national security in the United States. USARE is developing an NdFeB magnet manufacturing plant in the United States, and establishing domestic rare earth and critical minerals supply, extraction, and processing capabilities to both supply its manufacturing plant and market surplus materials to third parties. Rare earth magnets are critical to various business sectors and industries, including the defense, automotive, aviation, industrial, medical and consumer electronics industries.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: